TrialAdvances in therapy2024

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.

Tara F Carr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.